Search results for "risk factor"

showing 10 items of 4321 documents

Metabolic and anti-inflammatory effects of a home-based programme of aerobic physical exercise

2013

Summary Aims Regular exercise demonstrated the ability to provide enormous benefits to many diseases, atherosclerotic-based, degenerative and neoplastic, but also to grant anti-inflammatory actions, assessed by various authors in different populations. Despite of these clear benefits, many patients are unable to attain long-term results through chronic physical activity for different causes. On this basis, the aim of our study was to assess the metabolic and anti-inflammatory effects of a home-based programme of fast walking in patients affected by metabolic syndrome (MS). Materials and methods We enrolled 176 subjects with MS as stated by ATP III criteria. Patients were invited to walk for…

Malemedicine.medical_specialtyWaistSettore MED/09 - Medicina InternaFITNESSMetabolism aerobic physical exercisePopulationMonitoring AmbulatoryTYPE-2 DIABETES-MELLITUSPhysical exerciseBLOOD-PRESSUREWalkingINFLAMMATORY MARKERSBody Mass Indexchemistry.chemical_compoundRisk FactorsInternal medicineHumansMedicineExercise physiologyeducationOLDER-ADULTSExerciseInflammationMetabolic Syndromeeducation.field_of_studyHYPERTENSIONbusiness.industryCholesterolGeneral MedicineMiddle Agedmedicine.diseaseHome Care ServicesC-REACTIVE PROTEINExercise TherapychemistryATHEROSCLEROSISCardiovascular DiseasesCARDIOVASCULAR-DISEASEAmbulatoryPhysical therapyFemaleHEALTHSedentary BehaviorWaist CircumferenceMetabolic syndromeEnergy MetabolismbusinessBody mass index
researchProduct

Basal growth hormone concentrations in blood and the risk for prostate cancer: A case-control study

2005

OBJECTIVE To assess the relationship between basal serum growth hormone (GH) levels and prostate cancer risk. METHODS We conducted a population-based case-control study; cases included 68 men, aged 45–85 years, diagnosed with incident, primary, histologically confirmed, and clinically apparent (stage B and higher) prostate cancer. Controls included 240 men, frequency matched on age and residential area. Age, race, BMI, waist circumference, history of enlarged prostate, education, and current smoking status, were all considered as possible confounders. RESULTS We found a statistically significant trend of decreasing prostate cancer risk across increasing GH quintiles, in both crude (OR: 0.31…

Malemedicine.medical_specialtyWaistUrologyPopulationGastroenterologyProstate cancerBasal (phylogenetics)Risk FactorsInternal medicineBiomarkers TumormedicineHumansInsulin-Like Growth Factor IRisk factoreducationAgedAged 80 and overeducation.field_of_studybusiness.industryConfoundingCase-control studyProstatic NeoplasmsMiddle Agedmedicine.diseaseGrowth hormone secretionEndocrinologyOncologyCase-Control StudiesGrowth HormonebusinessThe Prostate
researchProduct

Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensiv…

2018

Obesity is a well‐known risk factor for the development and progression of chronic kidney disease. Recently, para‐perirenal ultrasonographic fat thickness (PUFT) has shown to correlate with both total and visceral fat better than body mass index (BMI), waist circumference (WC), and other indices of obesity. Moreover, a local paracrine and mechanical action of the PUFT on kidney has been described in recent studies. Aim of our study was to assess the relationship between glomerular filtration rate (GFR) and PUFT in comparison with other anthropometric and ultrasonographic indices of adiposity. Two hundred and ninety‐six hypertensive patients were enrolled. PUFT, cutis‐rectis thickness and re…

Malemedicine.medical_specialtyWaisthypertensionEndocrinology Diabetes and Metabolism030232 urology & nephrologyUrologyRenal functionrenal damageIntra-Abdominal Fat030204 cardiovascular system & hematologyadiposity; glomerular filtration rate; hypertension; para-perirenal fat thickness; renal damage; Internal Medicine; Endocrinology Diabetes and Metabolism; Cardiology and Cardiovascular MedicineBody Mass Index03 medical and health sciencesEndocrinology0302 clinical medicinePredictive Value of TestsRisk Factorspara-perirenal fat thicknemedicineInternal MedicineBody Fat DistributionHumansRenal Insufficiency ChronicRisk factorAgedUltrasonographyadiposityglomerular filtration rateAnthropometryReceiver operating characteristicbusiness.industrypara-perirenal fat thicknessConfoundingArea under the curveMiddle Agedmedicine.diseaseDiabetes and MetabolismCross-Sectional StudiesHypertension and ObesityFemaleWaist CircumferencebusinessCardiology and Cardiovascular MedicineBody mass indexKidney disease
researchProduct

Equally Interchangeable? How Sex and Gender Affect Transplantation

2019

Organ transplantation as an option to overcome end-stage diseases is common in countries with advanced healthcare systems and is increasingly provided in emerging and developing countries. A review of the literature points to sex- and gender-based inequity in the field with differences reported at each step of the transplant process, including access to a transplantation waiting list, access to transplantation once waitlisted, as well as outcome after transplantation. In this review, we summarize the data regarding sex- and gender-based disparity in adult and pediatric kidney, liver, lung, heart, and hematopoietic stem cell transplantation and argue that there are not only biological but al…

Malemedicine.medical_specialtyWaiting ListsDeveloping country030230 surgeryRisk AssessmentOrgan transplantationDonor Selection03 medical and health sciencesPostoperative ComplicationsSex Factors0302 clinical medicineRisk FactorsmedicineHumansHealthcare DisparitiesIntensive care medicineSocioeconomic statusSex CharacteristicsTransplantationEquity (economics)Donor selectionbusiness.industryGraft SurvivalGender IdentityHealth Status DisparitiesOrgan TransplantationTissue DonorsTransplantationTreatment Outcomesurgical procedures operativeFemale030211 gastroenterology & hepatologybusinessRisk assessmentSex characteristics
researchProduct

Inguinal hernia and certain risk factors

1992

There are several studies on inguinal hernias that give some clues about the association between this type of hernia and certain risk factors. This association was suspected long ago but had not been demonstrated. The present study tries to correlate the origin of inguinal hernias and the physical effort of the subjects in accordance with their work activity. The results of this study show that physical effort, as a risk factor, is closely related to the appearance of inguinal hernias. A person whose work involves lifting or other strenuous exertion has a higher risk than those whose jobs are less strenuous (p less than 0.05). This conclusion was reached after taking into account not only t…

Malemedicine.medical_specialtyWork activityAlcohol DrinkingEpidemiologyPhysical ExertionHernia InguinalBody weightRisk FactorsEpidemiologymedicineHumansHerniaExertionRisk factorRetrospective Studiesbusiness.industryGeneral surgeryBody WeightRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryInguinal herniaFemalebusinessEuropean Journal of Epidemiology
researchProduct

Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism

2021

Abstract Background Venous thromboembolism (VTE) is common and associated with high morbidity and mortality. Although chronic inflammation was not categorized as a traditional risk factor for VTE, chronic inflammation might increase the risk to develop VTE events. While studies confirmed an increased cardiovascular morbidity and mortality in psoriatic patients, data regarding the influence of psoriasis on patients' cardiovascular profile and on prognosis of patients with pulmonary embolism (PE) are sparse. Purpose We aimed to investigate the impact of psoriasis on prognosis of PE patients. Methods Hospitalized PE patients were stratified for psoriasis and the impact of psoriasis on outcome …

Malemedicine.medical_specialtyYounger agebusiness.industryVenous Thromboembolismmedicine.diseasePulmonary embolismVenous thrombosisIncreased riskRisk FactorsInternal medicinePsoriasismedicineHumansPsoriasisFemaleHospital MortalityPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessVenous thromboembolismAgedEuropean Heart Journal
researchProduct

Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and no…

2020

Patients with familial hypercholesterolemia (FH) are prone to develop acute myocardial infarction (AMI) at a younger age.The aim of the present study was to assess 5-year outcomes after AMI according to the presence of FH in a large multicenter cohort of patients.The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction consists of nationwide surveys recruiting patients over a 1- to 2-month period every 5 years. Patients recruited in 2005 and 2010 were followed up to 5 years.Of 5147 patients discharged alive and in whom FH status could be assessed, 2.8% had probable/definite FH, using an adapted Dutch Lipid Clinic score. They were 12 years younger, on average, tha…

Malemedicine.medical_specialty[SDV]Life Sciences [q-bio]Endocrinology Diabetes and MetabolismFamilial hypercholesterolemia030204 cardiovascular system & hematologyCohort StudiesHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineSurveys and QuestionnairesInternal MedicinemedicineHumansIn patient030212 general & internal medicineMyocardial infarctionRegistriesNon-ST Elevated Myocardial InfarctionStrokeComputingMilieux_MISCELLANEOUSAgedNutrition and Dieteticsbusiness.industryST elevationHazard ratioMiddle Agedmedicine.diseasePrognosisConfidence interval3. Good healthCohortST Elevation Myocardial Infarction[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessJournal of clinical lipidology
researchProduct

Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction

2017

Abstract Objectives The study sought to assess the outcome of percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) in patients with low left ventricular ejection fraction (LVEF) (≤35%). Background Data regarding the outcome of PCI in patients with low LVEF affected by CTO are scarcely reported. Methods The authors performed a prospective longitudinal multicenter study including consecutive patients undergoing elective PCI of CTOs. Patients were subdivided into 3 groups: group 1 (LVEF ≥50%), group 2 (LVEF 35% to 50%), and group 3 (LVEF ≤35%). Results A total of 839 patients (mean 64.6 ± 10.5 years of age, 87.7% men) underwent CTO PCI attempts. Baseline LVEF ≤35% was pr…

Malemedicine.medical_specialtyanimal structuresTime Factorsmedicine.medical_treatment610 Medicine & healthKaplan-Meier Estimate030204 cardiovascular system & hematologyCoronary AngiographyDisease-Free SurvivalVentricular Function Left2705 Cardiology and Cardiovascular Medicinechronic total occlusion; ischemic LV dysfunction; left ventricular ejection fraction; PCI; Cardiology and Cardiovascular Medicinechronic total occlusionischemic LV dysfunctionleft ventricular ejection fractionPCI03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineHumansIn patientcardiovascular diseases030212 general & internal medicineLongitudinal StudiesProspective Studieschronic total occlusionAgedProportional Hazards ModelsEjection fractionbusiness.industryPercutaneous coronary interventionleft ventricular ejection fractionPCIStroke VolumeRecovery of FunctionMiddle AgedSurgeryEuropeTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseCardiology10209 Clinic for CardiologyFemalebusinessCardiology and Cardiovascular Medicineischemic LV dysfunction
researchProduct

Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases

2011

In the last few decades, the prevalence of overweight and essential obesity has been undergoing a fast and progressive worldwide increase. Obesity has been in turn linked to type II diabetes, with the total number of diabetic patients worryingly increasing, in the last fifteen years, suggesting a pandemic phenomenon. At the same time, an increase in the prevalence of cardiovascular diseases has been also recorded. Increasing evidence suggests that the diet is involved in such escalation. In particular, the progressive globalization of food industry allowed massive supply, at a relatively low price, of a great variety of pre-packed food and bakery products, with very high energy content. Mos…

Malemedicine.medical_specialtycoronary heart disease (CHD)Endocrinology Diabetes and MetabolismTransportCoronary DiseaseType 2 diabetesOverweightEndocrinologyInsulin resistanceRisk FactorsSettore BIO/10 - BiochimicaInternal medicineDiabetes mellitusPrevalencemedicineHumansObesityMetabolic Syndromechemistry.chemical_classificationtype 2 diabeteFree fatty acidbusiness.industryFatty AcidsMetabolismTrans Fatty AcidsFatty acidsignaling fatty acidLipid Metabolismmedicine.diseaseDietary FatsObesityDietMetabolismEndocrinologychemistryFemaleFFA-dependent β-cell apoptosiHydrogenationInsulin Resistancemedicine.symptomMetabolic syndromebusinessDiabetic AngiopathiesPolyunsaturated fatty acidCurrent Diabetes Reviews
researchProduct

Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or s…

2021

Aims Combination therapy of 5α‐reductase inhibitor and α‐blocker is a guideline‐endorsed therapeutic approach for patients with moderate‐to‐severe lower urinary tract symptoms or benign prostatic hyperplasia (LUTS/BPH) who are at risk of disease progression. We aimed to disentangle the contribution of clinical and demographic baseline characteristics affecting the risk of acute urinary retention or BPH‐related surgery (AUR/S) from the effect of treatment with drugs showing symptomatic and disease‐modifying properties. Methods A time‐to‐event model was developed using pooled data from patients (n = 10 238) enrolled into six clinical studies receiving placebo, tamsulosin, dutasteride or tamsu…

Malemedicine.medical_specialtydisease‐modifying propertiesCombination therapyProstatic HyperplasiaPlacebo030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinebaseline risk factorsLower urinary tract symptomsTamsulosinHumansMedicinePharmacology (medical)lower urinary tract symptoms030212 general & internal medicineacute urinary retentionPharmacologybenign prostatic hyperplasiadutasterideSulfonamidesbusiness.industryUrinary retentionHazard ratioOriginal ArticlesUrinary Retentionmedicine.diseaseDutasterideSurgeryTreatment OutcomechemistryAzasteroidstamsulosinOriginal ArticleDrug Therapy CombinationInternational Prostate Symptom Scoremedicine.symptombusinesstime‐to‐event modellingmedicine.drugBritish Journal of Clinical Pharmacology
researchProduct